Wearable Technology to Assess Gait Function in SMA and DMD
study id #: NCT04193085
condition: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy
status: Recruiting
purpose:The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.
results: https://clinicaltrials.gov/ct2/show/results/NCT04193085
last updated: February 04, 2022
-
Spinal Muscular Atrophy Type 2 (Intermediate SMA)Spinal muscular atrophy (SMA) is a genet...
-
Charlotte Jane Sumner, MDDr. Charlotte Sumner is a Professor of N...
-
Living With Adult Spinal Muscular AtrophyMark Aldrich is a sharp, thoughtful 52-y...
-
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is a rare,...
-
Muscular Dystrophy AssociationMDA's legacy of progress has always star...
-
Nusinersen: A Review in 5q Spinal Muscular AtrophySurvival motor neuron 1 (SMN1), located ...
-
Karen S. Chen, PhDKaren Chen is the Chief Executive Office...